90.12 ± 17.23 μmol/L, p < 0.05), and an increasing trend in creatinine was observed in the TDF group.
← all excerpts
Efficacy and safety of tenofovir amibufenamide in patients with chronic hepatitis B: a real-world clinical study.
1
—
—
90.12 ± 17.23 μmol/L, p < 0.05), and an increasing trend in creatinine was observed in the TDF group.